Shanghai Minwei Biotechnology Co., Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING2
READOUTS ≤12 MONTHS2
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| MWN109 1 NCT07804797 |
P2 | Active, not recruiting | Overweight , Obesity | 71 | 2026-09 |
| MWN109 1 NCT07791537 |
P2 | Active, not recruiting | Overweight , Obesity | 125 | 2026-10 |
| MWN109 1 NCT07801820 |
P2 | Recruiting | Type 2 Diabetes Mellitus (T2DM) | 240 | 2027-03 |
| MWN109 1 NCT07778693 |
P3 | Not yet recruiting | Overweight , Obesity | 760 | 2027-09 |
| MWX203 NCT07803822 |
P2 | Recruiting | Mixed Dyslipidemia | 216 | 2028-02 |